Comments
Cadila Healthcare Ltd (Zydus Cadila) has reported a sharp jump in consolidated net profit of 52 per cent at Rs 282 crore for the quarter ended December 31, 2014, against Rs 186 crore in the corresponding period last year.
The company's total Income from operations on a consolidated basis stood at Rs 2,190 crore, up 17 per cent, from Rs 1,872 crore in the corresponding period last year.
During the quarter, Cadila Healthcare's business in the US grew 42 per cent and Emerging Markets business grew 23 per cent. During the quarter, the company had filed five additional ANDAs (abbreviated new drug applications) with the USFDA taking the cumulative ANDA filings to 255.
Cadila Healthcare shares ended positive at Rs 1,510 on Tuesday, up 2.33 per cent, from the previous close on the Bombay Stock Exchange.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.